Pfizer Q3 Results - Q3 Top Pharma Company Earnings Reports

View Pfizer's Q3 Earnings Report

FiercePharma says: The good news: Pfizer delivered a big increase in third-quarter profits; 26 percent, to be exact. The bad: revenues slipped 3 percent, highlighting the fact that cost-cutting boosted earnings, not product performance. (Nonetheless, sales did beat analyst estimates.) Read more of our coverage here...

Highlights:

• Third-Quarter 2009 Revenues of $11.6 Billion
• Third-Quarter 2009 Reported Diluted EPS⁽¹⁾ of $0.43, Adjusted Diluted EPS⁽²⁾ of $0.51
• Continues to Execute on Financial and Strategic Commitments; Commenced Wyeth Integration on October 16, 2009 Following Completion of the Acquisition
• Updates Full-Year 2009 Revenue, Reported Diluted EPS⁽¹⁾ and Adjusted Diluted EPS⁽²⁾ Guidance to Reflect Wyeth Acquisition

Check out Pfizer's current earnings estimates from CNN Money

Pfizer's Website http://www.pfizer.com/home/

Related Articles:
Pfizer/Wyeth merger could eliminate $3B, R&D jobs
Pfizer plans dramatic increase in new cancer drugs
Generics expected to hit Merck, Pfizer earnings
Pfizer moves to cap retiree health benefits